— Fruquintinib treatment reduced the risk of death by 34% in metastatic colorectal cancer (0.66…
– Presentation at World ADC Conference in San Diego – – CX-2051 integrates CytomX core…
Top-line findings will be presented Sept. 10 at the annual European Society for Medical Oncology…
MENLO PARK, CA & HYDERBAD, IN, Sep 8, 2022 – (ACN Newswire) – TheCapitalNet, Inc.,…
NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare…
Part A results from the two-part Phase 2 LILAC study show litifilimab significantly reduced disease…
PRINCETON, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster…
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
David Grand has Resigned as CEO and Chairman of the Company Effective Immediately to Pursue…
Leverages Arcutis’ deep dermatology expertise and broad biologics experience to accelerate Ducentis’ lead compound, DS-234,…
BUFFALO, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Montrouge, France, September 7, 2022 DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using…
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract…
BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
23% (6/26) of patients with RAS/MAPK-altered non-CRC solid tumors and 44% (4/9) with BRAF-driven non-CRC…
FOSTER CITY, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a provider of digital…
Andrew Elinesky, Former CFO of Reklaim, joins the board of directors to help provide additional…
Wilmington, Delaware–(Newsfile Corp. – September 7, 2022) – Acorn Energy, Inc. (OTCQB: ACFN), a provider…